{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:29:26Z","timestamp":1788334166879,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013648","name":"Hong Kong Breast Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jinf.2017.10.016","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T03:49:17Z","timestamp":1511495357000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Pentraxin-3 as a marker of sepsis severity and predictor of mortality outcomes: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"76","author":[{"given":"Yee Ting","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Tak","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bazoukis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny Hei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Lampropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William K.K.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5510-1253","authenticated-orcid":false,"given":"Gary","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jinf.2017.10.016_bib0010","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"Suppl 4","key":"10.1016\/j.jinf.2017.10.016_bib0015","first-page":"7","article-title":"Biomarkers for sepsis: what is and what might be?","volume":"10","author":"Biron","year":"2015","journal-title":"Biomark Insights"},{"issue":"2","key":"10.1016\/j.jinf.2017.10.016_bib0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jinf.2017.10.016_bib0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","article-title":"Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility","volume":"23","author":"Garlanda","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jinf.2017.10.016_bib0030","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.jinf.2017.10.016_bib0035","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3109\/14767058.2014.947574","article-title":"Pentraxin 3 concentrations of the mothers with preterm premature rupture of membranes and their neonates, and early neonatal outcome","volume":"28","author":"Akin","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.jinf.2017.10.016_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073119","article-title":"Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome","volume":"8","author":"Bastrup-Birk","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.016_bib0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/eci.12704","article-title":"Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial","volume":"47","author":"Caironi","year":"2017","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jinf.2017.10.016_bib0050","article-title":"Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients","author":"Fan","year":"2016","journal-title":"J Micro Immunol Inf"},{"key":"10.1016\/j.jinf.2017.10.016_bib0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13054-016-1210-z","article-title":"Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study","volume":"20","author":"Hansen","year":"2016","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.016_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017653","article-title":"High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study","volume":"6","author":"Huttunen","year":"2011","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.016_bib0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.amjms.2017.01.003","article-title":"Pentraxin 3, a predicator for 28-day mortality in patients with septic shock","volume":"353","author":"Jie","year":"2017","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.jinf.2017.10.016_bib0070","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3349\/ymj.2017.58.2.370","article-title":"Long pentraxin 3 as a predictive marker of mortality in severe septic patients who received successful early goal-directed therapy","volume":"58","author":"Kim","year":"2017","journal-title":"Yonsei Med J"},{"issue":"2","key":"10.1016\/j.jinf.2017.10.016_bib0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.hrtlng.2012.11.005","article-title":"Pentraxin 3 in the assessment of ventilator-associated pneumonia: an early marker of severity","volume":"42","author":"Lin","year":"2013","journal-title":"Heart Lung"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.016_bib0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00134-010-1752-5","article-title":"Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality","volume":"36","author":"Mauri","year":"2010","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1016\/j.jinf.2017.10.016_bib0085","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/00003246-200107000-00017","article-title":"Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients","volume":"29","author":"Muller","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jinf.2017.10.016_bib0090","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12882-015-0167-5","article-title":"Putative novel mediators of acute kidney injury in critically ill patients: handling by continuous venovenous hemofiltration and effect of anticoagulation modalities","volume":"16","author":"Schilder","year":"2015","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.016_bib0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/SHK.0b013e31817fd543","article-title":"Pentraxin 3 and C-reactive protein in severe meningococcal disease","volume":"31","author":"Sprong","year":"2009","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.016_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053661","article-title":"Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study","volume":"8","author":"Uusitalo-Seppala","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jinf.2017.10.016_bib0105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jinf.2009.04.004","article-title":"Long pentraxin PTX3 is associated with mortality and disease severity in severe leptospirosis","volume":"58","author":"Wagenaar","year":"2009","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.016_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/IBRR\/2015\/17737","article-title":"Level of pentraxin-3 in patients with acute leukemia in septicemia and its prognostic value","volume":"4","author":"Elghandour","year":"2015","journal-title":"Int Blood Res Rev"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.016_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-007-9126-7","article-title":"Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3","volume":"28","author":"Mantovani","year":"2008","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.016_bib0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.shk.0000215319.06866.bd","article-title":"Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever","volume":"26","author":"Fraunberger","year":"2006","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.jinf.2017.10.016_bib0125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00004630-199909000-00004","article-title":"Procalcitonin as a marker for the early diagnosis of severe infection after thermal injury","volume":"20","author":"Sachse","year":"1999","journal-title":"J Burn Care Rehabil"},{"issue":"2","key":"10.1016\/j.jinf.2017.10.016_bib0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.burns.2006.07.001","article-title":"Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis?","volume":"33","author":"Lavrentieva","year":"2007","journal-title":"Burns"},{"issue":"6","key":"10.1016\/j.jinf.2017.10.016_bib0135","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.burns.2008.01.014","article-title":"Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cases","volume":"34","author":"Barati","year":"2008","journal-title":"Burns"},{"issue":"51","key":"10.1016\/j.jinf.2017.10.016_bib0140","doi-asserted-by":"crossref","first-page":"32615","DOI":"10.1016\/S0021-9258(18)31678-8","article-title":"Apexin, an acrosomal pentaxin","volume":"269","author":"Reid","year":"1994","journal-title":"J Biol Chem"},{"issue":"6912","key":"10.1016\/j.jinf.2017.10.016_bib0145","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature01195","article-title":"Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response","volume":"420","author":"Garlanda","year":"2002","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jinf.2017.10.016_bib0150","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6","article-title":"PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation","volume":"44","author":"Fazzini","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.016_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2004.09.004","article-title":"IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection","volume":"7","author":"Azzurri","year":"2005","journal-title":"Microbes Infect"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.016_bib0160","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jmv.20397","article-title":"Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections","volume":"76","author":"Mairuhu","year":"2005","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.jinf.2017.10.016_bib0165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jinf.2009.04.004","article-title":"Long pentraxin PTX3 is associated with mortality and disease severity in severe leptospirosis","volume":"58","author":"Wagenaar","year":"2009","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.jinf.2017.10.016_bib0170","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.102.6.636","article-title":"PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans","volume":"102","author":"Peri","year":"2000","journal-title":"Circulation"},{"issue":"2 Pt 1","key":"10.1016\/j.jinf.2017.10.016_bib0175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9378(99)70239-5","article-title":"Preeclampsia: an excessive maternal inflammatory response to pregnancy","volume":"180","author":"Redman","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"11\u201312","key":"10.1016\/j.jinf.2017.10.016_bib0180","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3109\/00365548.2011.600325","article-title":"Early detection of severe sepsis in the emergency room: diagnostic value of plasma C-reactive protein, procalcitonin, and interleukin-6","volume":"43","author":"Uusitalo-Seppala","year":"2011","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.016_bib0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000336629","article-title":"An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks","volume":"102","author":"Hofer","year":"2012","journal-title":"Neonatology"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.016_bib0190","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/CCM.0b013e318169eda9","article-title":"Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America","volume":"36","author":"O'Grady","year":"2008","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.jinf.2017.10.016_bib0195","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/421997","article-title":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis","volume":"39","author":"Simon","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.016_bib0200","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/CCM.0000000000000742","article-title":"Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database","volume":"43","author":"Casserly","year":"2015","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.jinf.2017.10.016_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178387","article-title":"Plasma kallistatin in critically ill patients with severe sepsis and septic shock","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.jinf.2017.10.016_bib0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178387","article-title":"Plasma kallistatin in critically ill patients with severe sepsis and septic shock","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.jinf.2017.10.016_bib0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.thromres.2005.06.007","article-title":"TAFI and PAI-1 levels in human sepsis","volume":"118","author":"Zeerleder","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.jinf.2017.10.016_bib0220","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-7-108","article-title":"Common TNF-\u03b1, IL-1\u03b2, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis","author":"Jessen","year":"2007","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2017.10.016_bib0225","doi-asserted-by":"crossref","first-page":"w13542","DOI":"10.4414\/smw.2012.13542","article-title":"Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia","volume":"142","author":"Suberviola","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jinf.2017.10.016_bib0230","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/951532","article-title":"Procalcitonin, MR-proadrenomedullin, and cytokines measurement in sepsis diagnosis: advantages from test combination","author":"Angeletti","year":"2015","journal-title":"Dis Markers"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.016_bib0235","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/cc10316","article-title":"Soluble CD40 ligand is not solely related to the presence and severity of sepsis","volume":"15","author":"Chew","year":"2011","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.jinf.2017.10.016_bib0240","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00011-010-0213-5","article-title":"Soluble CD40L (CD154) is increased in patients with shock","volume":"59","author":"Chew","year":"2010","journal-title":"Inflamm Res"},{"issue":"7","key":"10.1016\/j.jinf.2017.10.016_bib0245","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s00134-004-2184-x","article-title":"Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma","volume":"30","author":"Brunner","year":"2004","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.016_bib0250","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s00134-010-1773-0","article-title":"Soluble ST2 plasma concentrations predict mortality in severe sepsis","volume":"36","author":"Hoogerwerf","year":"2010","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.jinf.2017.10.016_bib0255","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3343\/alm.2015.35.6.570","article-title":"Soluble ST2 has a prognostic role in patients with suspected sepsis","volume":"35","author":"Hur","year":"2015","journal-title":"Ann Lab Med"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.016_bib0260","first-page":"205","article-title":"Soluble ST2 levels in patients with cardiogenic and septic shock are not predictors of mortality","volume":"17","author":"Parenica","year":"2012","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.jinf.2017.10.016_bib0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2017.09.030","article-title":"Novel biomarkers for sepsis: a narrative review","author":"Larsen","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jinf.2017.10.016_bib0270","doi-asserted-by":"crossref","DOI":"10.1007\/s12325-017-0622-8","article-title":"Sepsis: a review of advances in management","author":"Rello","year":"2017","journal-title":"Adv Ther"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445317303511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445317303511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:24:49Z","timestamp":1759008289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445317303511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0163445317303511"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2017.10.016","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentraxin-3 as a marker of sepsis severity and predictor of mortality outcomes: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2017.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}